Anavex Life Sciences Corp (AVXL)

[crescentmotor]

You want Anavex to run no trials for the next year (apart from the 3-71 schizophrenia trial, I assume?), or just no blarcamesine trials?

Yes--I saw my post needed editing but was too late. I'm all for moving forward with 3-71--schizophrenia is a large indication. Too further clarify, I would also agree with AVXL running a confirmatory trial (post FDA approval) with 2-73 in AD but I left that out since that may be a long shot and the cash position could become a limiting factor as AVXL gets down the road a little further.

"I take it "accepted" means "approved" (since there's no other "accepting" left for the EMA to do)."

Thanks--looks like I made a bad assumption that there was a formal acceptance step.